Western University

AVP Reinforces Its Leadership Team: Warda Shaheen Joins AVP as a General Partner for the AVP Late Stage Fund in Europe, while Pedro Barros Takes on the Role of Partner in Charge of Investor Relations

Retrieved on: 
星期四, 五月 16, 2024
Finance, Professional Services, Other Professional Services, Asset Management, Insurance, Partnership, Mechanical engineering, Coveo, Business administration, General partnership, Clio, HBA, Business, Investment, University, GitLab, Point72 Asset Management, Industrial engineering, Bain & Company, Partner, Deutsche Bank, MBA, AVP, PandaDoc, IPO, Economics, FINEP, Financial economics, Bachelor of Science, Mechanical, Software, Knowledge, Multimedia, Western University, Master of Science, Video game

In the context of the launch of its Late Stage Fund, AVP continues to strengthen its leadership team to reinforce its global platform.

Key Points: 
  • In the context of the launch of its Late Stage Fund, AVP continues to strengthen its leadership team to reinforce its global platform.
  • Previously, Warda worked in public markets at CPP Investments where she ran a $500M public markets portfolio in the thematic investing team.
  • Second, Pedro's appointment as Partner in charge of investor relations underlines AVP's objective of managing more capital for top tier institutional investors.
  • Warda will play a key role in developing our new Late Stage Fund strategy, focusing on Europe.

Results from Pivotal Clinical Study Demonstrate Potential of Nucleix’s Bladder EpiCheck® to Improve Disease Recurrence Detection in Non-Muscle Invasive Bladder Cancer (NMIBC) Surveillance

Retrieved on: 
星期一, 五月 6, 2024
Biotechnology, FDA, Health, General Health, Oncology, Health Technology, Other Science, Medical Devices, Research, Science, Clinical Trials, Western University, Cystoscopy, Risk, Food, Urinary bladder, American Urological Association, Recurrence, Trial of the century, PCR, Patient, AUA, MBA, Neoplasm, Clinical trial, Annual general meeting, Bladder cancer, Liquid biopsy, Medical imaging

The data presented demonstrated Bladder EpiCheck’s potential to improve timely disease recurrence detection and compliance with NMIBC surveillance.

Key Points: 
  • The data presented demonstrated Bladder EpiCheck’s potential to improve timely disease recurrence detection and compliance with NMIBC surveillance.
  • “The results from our pivotal clinical study not only underscore the potential of Bladder EpiCheck as a non-invasive method for tumor recurrence detection in patients previously diagnosed with NMIBC but also signal a transformative shift in NMIBC surveillance,” said Aharona Shuali, MD, MBA, Vice President of Medical Affairs at Nucleix.
  • “The performance of Bladder EpiCheck in this clinical trial demonstrates its potential to be used as a non-invasive test for detecting bladder cancer recurrence.
  • Ongoing research will determine if Bladder EpiCheck can be used to replace some cystoscopies and thereby reduce the burden of bladder cancer surveillance for patients and health systems alike.”
    During the AUA Annual Meeting on May 5, 2024, these results were presented by Dr. Inman in a podium presentation titled “Pivotal Study Evaluating Performance of Bladder EpiCheck, an FDA cleared test, in Non-Muscle Invasive Bladder Cancer.”

Model Medicines Appoints Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor

Retrieved on: 
星期三, 四月 24, 2024
Western University, University, Ecosystem, Tanimoto, Chairperson, Ivey Business School, Disease, RAC, Therapy, Patient, Chemistry, TRIO, Lethbridge, Biology, Pharmacy, Drug discovery, Growth, Medical device

LA JOLLA, Calif., April 24, 2024 /PRNewswire/ -- Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced the appointment of Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor. In this role, Dr. Aspeslet will provide strategic guidance and support to the company's executive team as they continue to scale their AI-driven drug discovery platform and advance their pipeline of novel therapeutics.

Key Points: 
  • LA JOLLA, Calif., April 24, 2024 /PRNewswire/ -- Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced the appointment of Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor.
  • Dr. Aspeslet brings over 25 years of progressive leadership and management experience in the life sciences industry.
  • "We are thrilled to welcome Dr. Aspeslet to the Model Medicines team," said Dr. Daniel Haders, CEO and Founder of Model Medicines.
  • "Throughout my career, I have witnessed the immense challenges and opportunities in bringing novel therapeutics to patients in need.

Seed Health Appoints Microbiome Pioneer Zain Kassam, M.D., M.P.H., as Chief Medical Officer

Retrieved on: 
星期三, 四月 24, 2024
Western University, Harvard University, Nature Biotechnology, Public health, Chairperson, Abstract, Health, McMaster University, OpenBiome, FMT, Janssen, IPO, Therapy, Science, Ecology, Alumni, Internal medicine, Bacillota, Longevity, Growth, MIT, Medical device

BOSTON, April 24, 2024 /PRNewswire/ -- Seed Health, a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer. An award-winning physician-scientist, Dr. Kassam has played a pivotal role in the advancement of microbiome science for over a decade. His extensive body of work includes over 200 peer-reviewed publications and abstracts, including in The New England Journal of Medicine, Nature Biotechnology, and Gastroenterology, and co-authoring international clinical practice guidelines. He has championed more than 30 Phase I-III clinical trials with top-tier academic institutions across multiple therapeutic areas. As Chief Medical Officer, Dr. Kassam will collaborate with Chief Scientific Officer, Dirk Gevers, Ph.D., to oversee Seed Health's R&D portfolio. He will expand the company's gut microbiome program and guide upcoming launches in the vaginal and skin microbiome sectors, as well as in brain health, metabolic health, and longevity.

Key Points: 
  • Dr. Kassam will lead Seed Health's clinical research and medical affairs, driving the
    BOSTON, April 24, 2024 /PRNewswire/ -- Seed Health , a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer.
  • As Chief Medical Officer, Dr. Kassam will collaborate with Chief Scientific Officer, Dirk Gevers, Ph.D., to oversee Seed Health's R&D portfolio.
  • He will expand the company's gut microbiome program and guide upcoming launches in the vaginal and skin microbiome sectors, as well as in brain health, metabolic health, and longevity.
  • Before joining Seed Health, Dr. Kassam co-founded and was Chief Medical Officer at two foundational microbiome therapeutics companies, OpenBiome and Finch Therapeutics.

B. Riley Farber Expands Western Canada Restructuring Practice with Senior Hire

Retrieved on: 
星期一, 四月 22, 2024
Western University, Agriculture, United, Business administration, AB, Ivey Business School, Senior, LOS, Mining, Partner, Aviation, Hospital

CALGARY, AB and LOS ANGELES, April 22, 2024 /PRNewswire/ -- B. Riley Farber, a wholly owned subsidiary of B. Riley Financial (NASDAQ: RILY) ("B. Riley"), is pleased to announce the addition of Ryan Adlington as Senior Managing Director, based in Calgary, Alberta.

Key Points: 
  • Ryan Adlington, veteran restructuring and turnaround expert, joins B. Riley as Senior Managing Director
    CALGARY, AB and LOS ANGELES, April 22, 2024 /PRNewswire/ -- B. Riley Farber, a wholly owned subsidiary of B. Riley Financial (NASDAQ: RILY) ("B. Riley"), is pleased to announce the addition of Ryan Adlington as Senior Managing Director, based in Calgary, Alberta.
  • Ryan is an experienced restructuring and turnaround expert with more than 20 years of experience in restructuring, financial advisory, and interim management roles, for both performing and underperforming companies.
  • He will lead B. Riley Farber's restructuring practice in Alberta, with a focus on growing the firm's footprint and team in Canada's Western region.
  • "Ryan's leadership and deep-industry expertise will be a key addition to our restructuring and financial advisory team," said Hylton Levy, co-head of Restructuring at B. Riley Farber.

Creyos Health Announces Addition of Dementia Screening, Testing, and Care Planning to its Online Platform

Retrieved on: 
星期二, 四月 9, 2024
Western University, Diagnosis, AMGA, Research, Dementia, Prevalence, Entrepreneurship, Deficit spending, Disease, Caregiver, Patient, American Medical Group Association, OBE, Doctor of Philosophy, Statistics, MCI, Cognition

This protocol, now available in the Creyos platform, is the result of 30 years of rigorous research and scientific validation.

Key Points: 
  • This protocol, now available in the Creyos platform, is the result of 30 years of rigorous research and scientific validation.
  • It offers full spectrum cognitive care, from early detection of mild cognitive impairment, to testing for an accurate dementia diagnosis, followed by tailored care planning, and ongoing longitudinal monitoring.
  • Dementia testing includes four additional tasks and behavioral health questionnaires, aligned with DSM-5 diagnostic criteria for dementia.
  • “We started Creyos because we noticed a significant gap in how cognitive health was being addressed,” said Marc Lipton, Co-Founder and CEO of Creyos.

Aduro Clean Technologies Provides Update on Joint Western University Research Project

Retrieved on: 
星期四, 四月 4, 2024
ACT, Western University, Oil, Benchmarking, Recycling, Partnership, LDPE, Knowledge, Monomer, Research, Pyrolysis, PP, Mentorship, Behavior, Chemistry, Plastic, Chemical substance, HDPE, HCT

Over the duration of the project, the research program will employ a total of 19 highly skilled research members and engineers.

Key Points: 
  • Over the duration of the project, the research program will employ a total of 19 highly skilled research members and engineers.
  • Building on our commitment to nurturing talent, Aduro has already offered positions to outstanding graduates from the project, enabling them to continue their impactful work as full-time Aduro employees.
  • “We are happy to provide this update and report on the significant project progress to date.
  • The synergistic relationship we've cultivated with Western University, is not only advancing critical research but also fostering the next generation of scientific leaders to join our team,” stated Ofer Vicus, CEO of Aduro.

Urology Care Foundation Announces 2024 Research Awards of Distinction

Retrieved on: 
星期四, 四月 4, 2024
Western University, Research, American Urological Association, Xenobiotic, Translational research, Postdoctoral researcher, Prostate cancer, Environment, Lawson Health Research Institute, Immunology, Committee, Gut microbiota, University, Macrophage, Doctor of Philosophy, Role, Publication, Pediatrics, University of California, Pediatric urology, Division, FACS, Radiation therapy, Society, Michigan Medicine, Nursing

BALTIMORE, April 04, 2024 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association, is pleased to announce the recipients of the 2024 Research Awards of Distinction.

Key Points: 
  • BALTIMORE, April 04, 2024 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association, is pleased to announce the recipients of the 2024 Research Awards of Distinction.
  • "We are optimistic about the future of urologic research with the selection of the recipients of this year’s Urology Care Foundation Research Awards,” said Harris M. Nagler, MD, Urology Care Foundation President.
  • “We are thrilled with the Urology Care Foundation Research Awards of Distinction awardees this year,” said Steven Kaplan, MD, Chair of the AUA’s Research Council.
  • The awardees will be celebrated at the Urology Care Foundation Research Honors Program held at the AUA Annual Meeting in May 2024.

Single mothers in particular would benefit from more subsidized housing in Canada

Retrieved on: 
星期二, 四月 9, 2024
Western University, Public housing, Federation, Policy, Woman, City, Housing, Government, Parent, Building

Housing prices have increased at double the rate of income growth over the past two decades.

Key Points: 
  • Housing prices have increased at double the rate of income growth over the past two decades.
  • To cope with housing affordability issues, people are increasingly “doubling up” with others and living in overcrowded housing.

Investing in subsidized housing

  • Many academics, policymakers, stakeholders and the media have emphasized the need for more subsidized housing units to tackle this crisis.
  • For example, in the city of Toronto, the wait time for a one-bedroom subsidized housing unit is 14 years.

National Housing Strategy


The federal government is taking steps to address Canada’s housing affordability crisis by implementing the National Housing Strategy. It has pledged to invest $82 billion to increase affordable housing. Roughly 25 to 33 per cent of these funds will be allocated to address the unmet housing needs of women and children. The implementation of the National Housing Strategy has raised two important questions:
To what extent does access to subsidized housing improve housing circumstances for Canadians?
What groups benefit the most from having access to subsidized housing?

Access to subsidized housing

  • To address these questions, our study investigates how living in subsidized housing affects children’s exposure to unaffordable and overcrowded housing.
  • Regardless of their family structure, children in subsidized housing are less likely than those in non-subsidized housing to experience housing affordability issues.
  • Conversely, the pattern of variation in children’s exposure to overcrowded housing according to their access to subsidized housing differs markedly between children in two-parent and other families.

Who benefits the most?

  • This compares with 65 per cent of children in two-parent families and 45 per cent of children in single-father families.
  • This compares with six per cent for children in single-father homes and 15 per cent for children without resident parents.

Implications for housing policy

  • It must rapidly build more subsidized housing units.
  • In doing so, the government can reduce the wait times for subsidized housing and offer more units to those with high levels of housing vulnerability.
  • Ottawa should also aim to better understand the needs of those in subsidized housing and build units that address these needs.


Kate Choi receives funding from the Social Sciences and Humanities Research Council (SSHRC).

Aptia Announces Jeff Williams as U.S. President

Retrieved on: 
星期二, 三月 5, 2024
Professional Services, Health, Other Professional Services, Insurance, Health Insurance, Human Resources, Finance, Western University, Multimedia, Brock University, Ivey Business School, Marketing, Pension, Growth, Habitat for Humanity, Retirement, MBA, United Way, Social responsibility, Marsh McLennan, ADP, Diversity, Business administration, Business, Knowledge, Harvard Business School, Humanity, Title, Alight Solutions, MMC, Management

New health, benefits, and pensions administrator Aptia today announced the appointment of Jeff Williams as U.S. President and CEO.

Key Points: 
  • New health, benefits, and pensions administrator Aptia today announced the appointment of Jeff Williams as U.S. President and CEO.
  • View the full release here: https://www.businesswire.com/news/home/20240305369517/en/
    Based out of Aptia’s U.S. headquarters in Boston, Jeff will be responsible for Aptia’s benefits administration services book of business and will report directly to Bala Viswanathan, Aptia Founder & Group CEO.
  • “We are excited to welcome Jeff to Aptia as he brings a wealth of experience and knowledge in the North American benefits administration industry,” said Viswanathan.
  • “I am incredibly excited to join Aptia and embark on this journey of growth and innovation,” said Williams.